Quality assessment and Q‐markers discovery in Citri Sarcodactylis Fructus by integrating serum pharmacochemistry and network pharmacology

Abstract

AbstractIntroductionCitri Sarcodactylis Fructus (CSF), a common fruit and traditional Chinese medicine (TCM), has been hindered in its further development and research owing to the lack of comprehensive and specific quality evaluation standards.ObjectiveThis study aimed to establish clear TCM quality standards related to the therapeutic mechanisms of CSF and to provide a basis for subsequent research and development.MethodsUltra‐high performance liquid chromatography coupled with hybrid quadrupole‐orbitrap high‐resolution mass spectrometry (UPLC‐Q‐orbitrap HRMS) technology was used to comprehensively identify CSF components and explore their absorbance levels in rat serum. Network pharmacology research methods were employed to investigate the potential mechanisms of action of the identified components in the treatment of major clinical diseases. Subsequently, a combination of HPLC chromatographic fingerprinting for qualitative analysis and multi‐index content determination was used to evaluate the detectability of the identified quality markers (Q‐markers).ResultsTwenty‐six prototype components were tentatively characterized in rat serum. Network pharmacology analysis showed six effective components, namely 7‐hydroxycoumarin, isoscopoletin, diosmin, hesperidin, 5,7‐dimethoxycoumarin, and bergapten, which played important roles in the treatment of chronic gastritis, functional dyspepsia, peptic ulcer, and depression and were preliminarily identified as Q‐markers. The results of content determination in 15 batches of CSF indicated significant differences in the content of medicinal materials from different origins. However, compared with the preliminarily determined Q‐markers, all six components could be measured and were determined as Q‐markers of CSF.ConclusionThe chemical Q‐markers obtained in this study could be used for effective quality control of CSF.